a five-year survival rate of 40% for a disease would mean that 40% of people, or 40 out of 100 people, are alive five years after being diagnosed. Median survival is the amount of time at which 50% of ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Pioneering the World's 1st Dark Matter Cancer Immunotherapy UbiVac's DPV-001 is the World's 1st Dark Matter Cancer Immunotherapy in the Cli ...

Esophageal cancer, particularly esophageal squamous cell carcinoma (ESCC), is one of the most prevalent digestive ...

Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...

Understanding the symptoms, causes, and risk factors of esophageal cancer is important for early detection and prevention.

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC ... With SCLC, the 5-year survival rate is about 7%. Without treatment, survival is ...

This study aims to explore the differences in perioperative inflammatory indices between lung squamous cell carcinoma (LSCC) and adenocarcinoma (LUAD) and their association with long-term outcomes.

Some 7,000 people a year are diagnosed with work-related cancers, research on behalf of cancer charity KWF Kankerbestrijding ...